aluates Reports

$ 0.0

Automative

Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2025

Published Date: September 2025

Report Code: QYRE-Auto-39H13951

Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2023

BUY CHAPTERS

Global Chronic Plaque Psoriasis Therapeutics Market Research Report 2025

Code: QYRE-Auto-39H13951

Report

September 2025

Pages:76

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

FEATURED COMPANIES

AbbVie

Novartis International

Pfizer Inc

Merck

Astelllas Pharma

GlaxoSmithKline PLC

Chronic Plaque Psoriasis Therapeutics Market Size

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years.

Chronic Plaque Psoriasis Therapeutics Market

The global market for Chronic Plaque Psoriasis Therapeutics was valued at US$ million in the year 2024 and is projected to reach a revised size of US$ million by 2031, growing at a CAGR of %during the forecast period.

Psoriasis is an autoimmune disease which is characterized by scaly patches of skin with inflammation and causes excessive production of new skin cells. Presently, there are no long term therapeutics available for the treatment of psoriasis. Chronic Plaque psoriasis is the one of the most common type of psoriasis. This disease condition is associated with several risk factors such as infection, psychological stress and others. Diagnosis of chronic plaque psoriasis is based on clinical appearance, is the case is severe then biopsy is recommended by the healthcare professionals in order to distinguish it from other conditions such as seborrheic dermatitis, ichen simplex chronicus and others.

The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

This report aims to provide a comprehensive presentation of the global market for Chronic Plaque Psoriasis Therapeutics, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Chronic Plaque Psoriasis Therapeutics.

The Chronic Plaque Psoriasis Therapeutics market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Chronic Plaque Psoriasis Therapeutics market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Chronic Plaque Psoriasis Therapeutics companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Chronic Plaque Psoriasis Therapeutics Market Report

Report Metric	Details
Report Name	Chronic Plaque Psoriasis Therapeutics Market
CAGR	5%
Segment by Type	Clinical Non-Clinical Inactive
Segment by Application	Hospitals Ambulatory Surgical Centers Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Abbvie, Novartis International, Pfizer, Merck, Astelllas Pharma, GlaxoSmithKline
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Chronic Plaque Psoriasis Therapeutics company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Chronic Plaque Psoriasis Therapeutics Market report?

Ans: The main players in the Chronic Plaque Psoriasis Therapeutics Market are Abbvie, Novartis International, Pfizer, Merck, Astelllas Pharma, GlaxoSmithKline

What are the Application segmentation covered in the Chronic Plaque Psoriasis Therapeutics Market report?

Ans: The Applications covered in the Chronic Plaque Psoriasis Therapeutics Market report are Hospitals, Ambulatory Surgical Centers, Others

What are the Type segmentation covered in the Chronic Plaque Psoriasis Therapeutics Market report?

Ans: The Types covered in the Chronic Plaque Psoriasis Therapeutics Market report are Clinical, Non-Clinical, Inactive

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Clinical

1.2.3 Non-Clinical

1.2.4 Inactive

1.3 Market by Application

1.3.1 Global Chronic Plaque Psoriasis Therapeutics Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Hospitals

1.3.3 Ambulatory Surgical Centers

1.3.4 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Chronic Plaque Psoriasis Therapeutics Market Perspective (2020-2031)

2.2 Global Chronic Plaque Psoriasis Therapeutics Growth Trends by Region

2.2.1 Global Chronic Plaque Psoriasis Therapeutics Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Chronic Plaque Psoriasis Therapeutics Historic Market Size by Region (2020-2025)

2.2.3 Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Region (2026-2031)

2.3 Chronic Plaque Psoriasis Therapeutics Market Dynamics

2.3.1 Chronic Plaque Psoriasis Therapeutics Industry Trends

2.3.2 Chronic Plaque Psoriasis Therapeutics Market Drivers

2.3.3 Chronic Plaque Psoriasis Therapeutics Market Challenges

2.3.4 Chronic Plaque Psoriasis Therapeutics Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue

3.1.1 Global Top Chronic Plaque Psoriasis Therapeutics Players by Revenue (2020-2025)

3.1.2 Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Players (2020-2025)

3.2 Global Chronic Plaque Psoriasis Therapeutics Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Chronic Plaque Psoriasis Therapeutics Revenue

3.4 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio

3.4.1 Global Chronic Plaque Psoriasis Therapeutics Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Chronic Plaque Psoriasis Therapeutics Revenue in 2024

3.5 Global Key Players of Chronic Plaque Psoriasis Therapeutics Head office and Area Served

3.6 Global Key Players of Chronic Plaque Psoriasis Therapeutics, Product and Application

3.7 Global Key Players of Chronic Plaque Psoriasis Therapeutics, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Chronic Plaque Psoriasis Therapeutics Breakdown Data by Type

4.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Type (2020-2025)

4.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2026-2031)

5 Chronic Plaque Psoriasis Therapeutics Breakdown Data by Application

5.1 Global Chronic Plaque Psoriasis Therapeutics Historic Market Size by Application (2020-2025)

5.2 Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Chronic Plaque Psoriasis Therapeutics Market Size (2020-2031)

6.2 North America Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025)

6.4 North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Chronic Plaque Psoriasis Therapeutics Market Size (2020-2031)

7.2 Europe Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025)

7.4 Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size (2020-2031)

8.2 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2020-2025)

8.4 Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Chronic Plaque Psoriasis Therapeutics Market Size (2020-2031)

9.2 Latin America Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025)

9.4 Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size (2020-2031)

10.2 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025)

10.4 Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Abbvie

11.1.1 Abbvie Company Details

11.1.2 Abbvie Business Overview

11.1.3 Abbvie Chronic Plaque Psoriasis Therapeutics Introduction

11.1.4 Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

11.1.5 Abbvie Recent Development

11.2 Novartis International

11.2.1 Novartis International Company Details

11.2.2 Novartis International Business Overview

11.2.3 Novartis International Chronic Plaque Psoriasis Therapeutics Introduction

11.2.4 Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

11.2.5 Novartis International Recent Development

11.3 Pfizer

11.3.1 Pfizer Company Details

11.3.2 Pfizer Business Overview

11.3.3 Pfizer Chronic Plaque Psoriasis Therapeutics Introduction

11.3.4 Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

11.3.5 Pfizer Recent Development

11.4 Merck

11.4.1 Merck Company Details

11.4.2 Merck Business Overview

11.4.3 Merck Chronic Plaque Psoriasis Therapeutics Introduction

11.4.4 Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

11.4.5 Merck Recent Development

11.5 Astelllas Pharma

11.5.1 Astelllas Pharma Company Details

11.5.2 Astelllas Pharma Business Overview

11.5.3 Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Introduction

11.5.4 Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

11.5.5 Astelllas Pharma Recent Development

11.6 GlaxoSmithKline

11.6.1 GlaxoSmithKline Company Details

11.6.2 GlaxoSmithKline Business Overview

11.6.3 GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Introduction

11.6.4 GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

11.6.5 GlaxoSmithKline Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

AbbVie

Novartis International

Pfizer Inc

Merck

Astelllas Pharma

GlaxoSmithKline PLC

List of Tables

Table 1. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Clinical

Table 3. Key Players of Non-Clinical

Table 4. Key Players of Inactive

Table 5. Global Chronic Plaque Psoriasis Therapeutics Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Chronic Plaque Psoriasis Therapeutics Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 7. Global Chronic Plaque Psoriasis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 8. Global Chronic Plaque Psoriasis Therapeutics Market Share by Region (2020-2025)

Table 9. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 10. Global Chronic Plaque Psoriasis Therapeutics Market Share by Region (2026-2031)

Table 11. Chronic Plaque Psoriasis Therapeutics Market Trends

Table 12. Chronic Plaque Psoriasis Therapeutics Market Drivers

Table 13. Chronic Plaque Psoriasis Therapeutics Market Challenges

Table 14. Chronic Plaque Psoriasis Therapeutics Market Restraints

Table 15. Global Chronic Plaque Psoriasis Therapeutics Revenue by Players (2020-2025) & (US$ Million)

Table 16. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players (2020-2025)

Table 17. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2024)

Table 18. Ranking of Global Top Chronic Plaque Psoriasis Therapeutics Companies by Revenue (US$ Million) in 2024

Table 19. Global 5 Largest Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue (CR5 and HHI) & (2020-2025)

Table 20. Global Key Players of Chronic Plaque Psoriasis Therapeutics, Headquarters and Area Served

Table 21. Global Key Players of Chronic Plaque Psoriasis Therapeutics, Product and Application

Table 22. Global Key Players of Chronic Plaque Psoriasis Therapeutics, Date of Enter into This Industry

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Chronic Plaque Psoriasis Therapeutics Market Size by Type (2020-2025) & (US$ Million)

Table 25. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2020-2025)

Table 26. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 27. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Type (2026-2031)

Table 28. Global Chronic Plaque Psoriasis Therapeutics Market Size by Application (2020-2025) & (US$ Million)

Table 29. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Application (2020-2025)

Table 30. Global Chronic Plaque Psoriasis Therapeutics Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 31. Global Chronic Plaque Psoriasis Therapeutics Revenue Market Share by Application (2026-2031)

Table 32. North America Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 33. North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 34. North America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 35. Europe Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 36. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 37. Europe Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 38. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 39. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2020-2025) & (US$ Million)

Table 40. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size by Region (2026-2031) & (US$ Million)

Table 41. Latin America Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 42. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 43. Latin America Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 44. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 45. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2020-2025) & (US$ Million)

Table 46. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size by Country (2026-2031) & (US$ Million)

Table 47. Abbvie Company Details

Table 48. Abbvie Business Overview

Table 49. Abbvie Chronic Plaque Psoriasis Therapeutics Product

Table 50. Abbvie Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025) & (US$ Million)

Table 51. Abbvie Recent Development

Table 52. Novartis International Company Details

Table 53. Novartis International Business Overview

Table 54. Novartis International Chronic Plaque Psoriasis Therapeutics Product

Table 55. Novartis International Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025) & (US$ Million)

Table 56. Novartis International Recent Development

Table 57. Pfizer Company Details

Table 58. Pfizer Business Overview

Table 59. Pfizer Chronic Plaque Psoriasis Therapeutics Product

Table 60. Pfizer Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025) & (US$ Million)

Table 61. Pfizer Recent Development

Table 62. Merck Company Details

Table 63. Merck Business Overview

Table 64. Merck Chronic Plaque Psoriasis Therapeutics Product

Table 65. Merck Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025) & (US$ Million)

Table 66. Merck Recent Development

Table 67. Astelllas Pharma Company Details

Table 68. Astelllas Pharma Business Overview

Table 69. Astelllas Pharma Chronic Plaque Psoriasis Therapeutics Product

Table 70. Astelllas Pharma Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025) & (US$ Million)

Table 71. Astelllas Pharma Recent Development

Table 72. GlaxoSmithKline Company Details

Table 73. GlaxoSmithKline Business Overview

Table 74. GlaxoSmithKline Chronic Plaque Psoriasis Therapeutics Product

Table 75. GlaxoSmithKline Revenue in Chronic Plaque Psoriasis Therapeutics Business (2020-2025) & (US$ Million)

Table 76. GlaxoSmithKline Recent Development

Table 77. Research Programs/Design for This Report

Table 78. Key Data Information from Secondary Sources

Table 79. Key Data Information from Primary Sources

Table 80. Authors List of This Report

List of Figures

Figure 1. Chronic Plaque Psoriasis Therapeutics Picture

Figure 2. Global Chronic Plaque Psoriasis Therapeutics Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Chronic Plaque Psoriasis Therapeutics Market Share by Type: 2024 VS 2031

Figure 4. Clinical Features

Figure 5. Non-Clinical Features

Figure 6. Inactive Features

Figure 7. Global Chronic Plaque Psoriasis Therapeutics Market Size by Application (2020-2031) & (US$ Million)

Figure 8. Global Chronic Plaque Psoriasis Therapeutics Market Share by Application: 2024 VS 2031

Figure 9. Hospitals Case Studies

Figure 10. Ambulatory Surgical Centers Case Studies

Figure 11. Others Case Studies

Figure 12. Chronic Plaque Psoriasis Therapeutics Report Years Considered

Figure 13. Global Chronic Plaque Psoriasis Therapeutics Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 14. Global Chronic Plaque Psoriasis Therapeutics Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 15. Global Chronic Plaque Psoriasis Therapeutics Market Share by Region: 2024 VS 2031

Figure 16. Global Chronic Plaque Psoriasis Therapeutics Market Share by Players in 2024

Figure 17. Global Top Chronic Plaque Psoriasis Therapeutics Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Chronic Plaque Psoriasis Therapeutics as of 2024)

Figure 18. The Top 10 and 5 Players Market Share by Chronic Plaque Psoriasis Therapeutics Revenue in 2024

Figure 19. North America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 20. North America Chronic Plaque Psoriasis Therapeutics Market Share by Country (2020-2031)

Figure 21. United States Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. Canada Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 23. Europe Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Europe Chronic Plaque Psoriasis Therapeutics Market Share by Country (2020-2031)

Figure 25. Germany Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. France Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 27. U.K. Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. Italy Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. Russia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Nordic Countries Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Asia-Pacific Chronic Plaque Psoriasis Therapeutics Market Share by Region (2020-2031)

Figure 33. China Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Japan Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 35. South Korea Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Southeast Asia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. India Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Australia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. Latin America Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Latin America Chronic Plaque Psoriasis Therapeutics Market Share by Country (2020-2031)

Figure 41. Mexico Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Brazil Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 43. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Middle East & Africa Chronic Plaque Psoriasis Therapeutics Market Share by Country (2020-2031)

Figure 45. Turkey Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Saudi Arabia Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 47. UAE Chronic Plaque Psoriasis Therapeutics Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Abbvie Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

Figure 49. Novartis International Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

Figure 50. Pfizer Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

Figure 51. Merck Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

Figure 52. Astelllas Pharma Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

Figure 53. GlaxoSmithKline Revenue Growth Rate in Chronic Plaque Psoriasis Therapeutics Business (2020-2025)

Figure 54. Bottom-up and Top-down Approaches for This Report

Figure 55. Data Triangulation

Figure 56. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Global Psoriasis Therapeutics Market Insights Forecast to 2030

Global Moderate to Severe Plaque Psoriasis Medications Market Research Report 2024

Global Psoriatic Arthritis Therapeutics Drug Market Insights Forecast to 2030

Global Psoriasis Treatment Drugs Market Research Report 2025

Global Biopharmaceuticals for Psoriasis Market Research Report 2024

Psoriasis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Psoriasis Biologics Drugs Market Research Report 2025

Global Psoriatic Arthritis Treatment Drugs Market Research Report 2025

Psoriatic Arthritis Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Monoclonal Antibodies for Plaque Psoriasis Market Research Report 2024

Global Pediatric Psoriasis Market Research Report 2024

Global Dermatology Therapeutics Devices Market Research Report 2024

Global Psoriasis Biosimilar Market Research Report 2024

Global TNF Inhibitors for the Treatment of Plaque Psoriasis Market Research Report 2024

Global Chronic Obstructive Pulmonary Disease Therapeutics Market Research Report 2024

Global Chronic Obstructive Pulmonary Disease Clinical Therapeutics Market Research Report 2025

Global Chronic Disease Treatment Market Research Report 2024

Plaquenil Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030

Global Scleroderma Therapeutics Market Insights Forecast to 2030

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions